| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Back Matter
|
|
|
|
141 |
15 |
p. II
|
artikel
|
| 2 |
B-ALL with synchronous MYC and BCL-2 rearrangement
|
Attieh, Michel
|
|
|
141 |
15 |
p. 1894
|
artikel
|
| 3 |
Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children’s Oncology Group report
|
Gossai, Nathan P.
|
|
|
141 |
15 |
p. 1802-1811
|
artikel
|
| 4 |
Editorial Board
|
|
|
|
141 |
15 |
p. xiv
|
artikel
|
| 5 |
Factor XII contributes to thrombotic complications and vaso-occlusion in sickle cell disease
|
Sparkenbaugh, Erica M.
|
|
|
141 |
15 |
p. 1871-1883
|
artikel
|
| 6 |
FXII and sickle cell: the clot thickens
|
Shet, Arun S.
|
|
|
141 |
15 |
p. 1787-1789
|
artikel
|
| 7 |
Gold is gold even in mud: NPM1 mutations in T-AML
|
Ustun, Celalettin
|
|
|
141 |
15 |
p. 1784-1785
|
artikel
|
| 8 |
Hardison RC. Promoter competition in globin gene control. Blood. 2022;139(14):2089-2091.
|
|
|
|
141 |
15 |
p. 1895-1896
|
artikel
|
| 9 |
Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings
|
Garcia, Jacqueline S.
|
|
|
141 |
15 |
p. 1884-1888
|
artikel
|
| 10 |
Location, location, location
|
Biernacki, Melinda A.
|
|
|
141 |
15 |
p. 1782-1783
|
artikel
|
| 11 |
Masthead Subscription
|
|
|
|
141 |
15 |
p. III
|
artikel
|
| 12 |
Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease
|
Penter, Livius
|
|
|
141 |
15 |
p. 1817-1830
|
artikel
|
| 13 |
MYB deficiency leads to myeloid neoplasia too
|
Gonda, Thomas J.
|
|
|
141 |
15 |
p. 1786-1787
|
artikel
|
| 14 |
MYB insufficiency disrupts proteostasis in hematopoietic stem cells, leading to age-related neoplasia
|
Clarke, Mary L.
|
|
|
141 |
15 |
p. 1858-1870
|
artikel
|
| 15 |
Novel insights into Hodgkin lymphoma biology by single-cell analysis
|
Aoki, Tomohiro
|
|
|
141 |
15 |
p. 1791-1801
|
artikel
|
| 16 |
Overlapping features of therapy-related and de novo NPM1-mutated AML
|
Othman, Jad
|
|
|
141 |
15 |
p. 1846-1857
|
artikel
|
| 17 |
PNH and complement gene variants
|
Risitano, Antonio M.
|
|
|
141 |
15 |
p. 1780-1782
|
artikel
|
| 18 |
Predictive value of staging PET/CT to detect bone marrow involvement and early outcomes in marginal zone lymphoma
|
Alderuccio, Juan Pablo
|
|
|
141 |
15 |
p. 1888-1893
|
artikel
|
| 19 |
Rare germline complement factor H variants in patients with paroxysmal nocturnal hemoglobinuria
|
Prata, Pedro Henrique
|
|
|
141 |
15 |
p. 1812-1816
|
artikel
|
| 20 |
SBNO2 is a critical mediator of STAT3-driven hematological malignancies
|
Brandstoetter, Tania
|
|
|
141 |
15 |
p. 1831-1845
|
artikel
|
| 21 |
Stein EM. IDH2 inhibition in AML. Blood. 2023;141(2):124-125.
|
|
|
|
141 |
15 |
p. 1896
|
artikel
|
| 22 |
Table of Contents
|
|
|
|
141 |
15 |
p. xi-xiii
|
artikel
|
| 23 |
T-ALL in CNS-3 status needs improvement
|
Ribera, Josep-Maria
|
|
|
141 |
15 |
p. 1779-1780
|
artikel
|
| 24 |
Tong C, Zhang Y, Liu Y, et al. Optimized tandem CD19/CD20 CAR-engineered T cells in refractory/relapsed B-cell lymphoma. Blood. 2020;136(14):1632-1644.
|
|
|
|
141 |
15 |
p. 1896
|
artikel
|
| 25 |
Wang D, Sun Z, Zhu X, et al. GARP-mediated active TGF-β1 induces bone marrow NK cell dysfunction in AML patients with early relapse post–allo-HSCT. Blood. 2022;140(26):2788-2804.
|
|
|
|
141 |
15 |
p. 1896
|
artikel
|
Tijdschrift beschrijving